Owners, management and financials
CVR: 20655305
DKK 1,199,350
Gross profit
Net result: DKK -39,942
Mattias Bodlund (50-66,65%), Morten Schjødt (50-66,65%)
CVR · view owners
Mattias Bodlund, Morten Schjødt
CVR · view management
Active
Founded 1 January 1998
CVR · view overview
4 employees
CVR · 2018
Owner registered: Mattias Bodlund
CVR · 11/01/2019
View the full event history
ONCOTYPE ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 1998. The company is registered under the industry Computerprogrammering. The management consists of Mattias Bodlund and Morten Schjødt. The company is owned by Mattias Bodlund and Morten Schjødt. The company has 4 employees (2018). In 2025, the company reported a gross profit of DKK 1,199,350 and a net result of DKK -39,942 compared with DKK -13,361 the year before. Equity in the 2025 report amounted to DKK 66,680.
Source: annual report 2025, Danish Business Authority
ONCOTYPE ApS demonstrates a fluctuating financial health with a recent decline in profitability, reporting a loss of 39,942 DKK in 2025 after a profit of 5,763 DKK in 2023. Gross profit has remained relatively stable, peaking at 1,508,597 DKK in 2023, but the overall trend indicates increasing financial strain with diminishing equity, which fell from 119,983 DKK in 2023 to 66,680 DKK in 2025. The company has not disclosed revenue figures, making it challenging to assess its market position fully, but the consistent gross profit suggests a steady demand for its services. Key concerns include the declining equity and recent losses, which could impact its sustainability in the competitive computer programming industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at yde assistance i forbindelse med design og anden virksomhed i relation med internettet samt IT-virksomhed iøvrigt.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/07/2024 – 30/06/2025 | 1.2 mio. | -40 t. | 631 t. | 67 t. | 2 | |
| 202401/07/2023 – 30/06/2024 | 1.2 mio. | -13 t. | 755 t. | 107 t. | 2 | |
| 202301/07/2022 – 30/06/2023 | 1.5 mio. | 6 t. | 843 t. | 120 t. | 2 | |
| 202201/07/2021 – 30/06/2022 | 1.2 mio. | 6 t. | 841 t. | 114 t. | 2 | |
| 202101/07/2020 – 30/06/2021 | 1.2 mio. | 4 t. | 758 t. | 108 t. | 2 | |
| 202001/07/2019 – 30/06/2020 | 1.2 mio. | 6 t. | 780 t. | 105 t. | 2 | |
| 201901/07/2018 – 30/06/2019 | 1.5 mio. | 1 t. | 712 t. | 99 t. | 3 | |
| 201801/07/2017 – 30/06/2018 | 2 mio. | 24 t. | 970 t. | 97 t. | 4 | |
| 201701/07/2016 – 30/06/2017 | 2 mio. | -56 t. | 777 t. | 73 t. | 4 | |
| 201601/07/2015 – 30/06/2016 | 1.6 mio. | 3 t. | 641 t. | 129 t. | - | |
| 201501/07/2014 – 30/06/2015 | 2.1 mio. | 13 t. | 744 t. | 126 t. | - | |
| 201401/07/2013 – 30/06/2014 | 1.3 mio. | -51 t. | 511 t. | 114 t. | - | |
| 201301/07/2012 – 30/06/2013 | 1.4 mio. | 23 t. | 491 t. | 165 t. | - |
Compared to 4.561 companies in Computerprogrammering
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of ONCOTYPE ApS is 20655305.
ONCOTYPE ApS is owned by Mattias Bodlund and Morten Schjødt.
The management of ONCOTYPE ApS consists of Mattias Bodlund and Morten Schjødt.
In 2025, ONCOTYPE ApS reported a gross profit of DKK 1,199,350.
ONCOTYPE ApS had 4 employees in 2018 according to the Danish CVR register.
ONCOTYPE ApS was founded on 1 January 1998.
Claim this page to add your logo and social links. Free to get started.
ONCOTYPE ApS has published its annual report for 2025. Gross profit came to DKK 1,199,350, and the net result was DKK -39,942.
ONCOTYPE ApS has published its annual report for 2024. Gross profit came to DKK 1,203,372, and the net result was DKK -13,361.
ONCOTYPE ApS has published its annual report for 2023. Gross profit came to DKK 1,508,597, and the net result was DKK 5,763.
ONCOTYPE ApS has published its annual report for 2022. Gross profit came to DKK 1,230,470, and the net result was DKK 5,851.
ONCOTYPE ApS has published its annual report for 2021. Gross profit came to DKK 1,248,773, and the net result was DKK 3,858.
ONCOTYPE ApS has published its annual report for 2020. Gross profit came to DKK 1,175,203, and the net result was DKK 5,566.
ONCOTYPE ApS has published its annual report for 2019. Gross profit came to DKK 1,519,621, and the net result was DKK 1,466.
As of January 11, 2019, Mattias Bodlund is registered as an owner of ONCOTYPE ApS with an ownership share of 50%.
As of January 11, 2019, Morten Schjødt is registered as an owner of ONCOTYPE ApS with an ownership share of 50%.
As of January 1, 2019, Morten Rylander Westermann has stepped down as director of ONCOTYPE ApS.
ONCOTYPE ApS has published its annual report for 2018. Gross profit came to DKK 2,024,013, and the net result was DKK 24,036.
ONCOTYPE ApS has published its annual report for 2017. Gross profit came to DKK 2,008,448, and the net result was DKK -55,991.
As of December 11, 2017, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of ONCOTYPE ApS.
ONCOTYPE ApS has published its annual report for 2016. Gross profit came to DKK 1,645,174, and the net result was DKK 2,946.
ONCOTYPE ApS has published its annual report for 2015. Gross profit came to DKK 2,057,426, and the net result was DKK 12,626.
ONCOTYPE ApS has published its annual report for 2014. Gross profit came to DKK 1,271,444, and the net result was DKK -50,666.
ONCOTYPE ApS has published its annual report for 2013. Gross profit came to DKK 1,406,575, and the net result was DKK 23,160.
As of March 1, 2008, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of ONCOTYPE ApS.
As of March 1, 2008, BOMHUSVEJ A/S has stepped down as auditor of ONCOTYPE ApS.
As of September 28, 2007, BOMHUSVEJ A/S has been appointed auditor of ONCOTYPE ApS.
As of September 28, 2007, REVISORERNE RANDERSGADE 60 STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of ONCOTYPE ApS.
As of December 18, 2001, REVISORERNE RANDERSGADE 60 STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of ONCOTYPE ApS.
As of December 18, 2001, A/S PSE NR. 5197 has stepped down as auditor of ONCOTYPE ApS.
As of March 1, 2001, Mattias Bodlund is registered as director of ONCOTYPE ApS.
As of March 1, 2001, Morten Rylander Westermann is registered as director of ONCOTYPE ApS.
As of March 1, 2001, Morten Schjødt is registered as director of ONCOTYPE ApS.
As of March 1, 2001, Theis Barenkopf Dinesen has stepped down as director of ONCOTYPE ApS.
As of March 11, 1999, A/S PSE NR. 5197 has been appointed auditor of ONCOTYPE ApS.
As of March 11, 1999, A/S PSE NR. 5197 has stepped down as auditor of ONCOTYPE ApS.
As of August 13, 1998, A/S PSE NR. 5197 has been appointed auditor of ONCOTYPE ApS.
As of August 13, 1998, JUT NR. 2180 A/S has stepped down as auditor of ONCOTYPE ApS.
As of August 13, 1998, Theis Barenkopf Dinesen is registered as director of ONCOTYPE ApS.
As of August 13, 1998, Peter Andreas Stakemann has stepped down as director of ONCOTYPE ApS.
As of January 1, 1998, JUT NR. 2180 A/S has been appointed auditor of ONCOTYPE ApS.
As of January 1, 1998, Peter Andreas Stakemann is registered as director of ONCOTYPE ApS.
ONCOTYPE ApS was founded on January 1, 1998.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 42188603
CVR 43228447
CVR 46187946
CVR 32020836
CVR 26292719
